Tag: FDA orphan act

Orphan Drug Exclusivity: Protection for Rare-Disease Medicines and Patent Timelines

Orphan Drug Exclusivity: Protection for Rare-Disease Medicines and Patent Timelines

Explore the mechanics of orphan drug exclusivity, a seven-year FDA protection designed to incentivize rare-disease medicine development. Learn how this regulatory shield differs from patents.

Read more